Inspira Technologies OXY B.H.N. Ltd. IINN recently announced plans to report clinical results for its new HYLA blood sensor in open-heart surgery patients. Since the medical industry is highly ...
Inspira announced results for its HYLA blood sensor, achieving 97.35% accuracy in its latest performance testing phase that will support its upcoming U.S. Food and Drug Administration submission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback